Article
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.
Cancer cell - 8 May 2017
Spranger Stefani, Dai Daisy, Horton Brendan, Gajewski Thomas F
Abstract excerpt
Effector T cells have the capability of recognizing and killing cancer cells. However, whether tumors can become immune resistant through exclusion of effector T cells from the tumor microenvironment is not known. By using a tumor model resembling non-T cell-inflamed human tumors, we assessed whether adoptive T cell transfer might overcome failed spontaneous priming. Flow cytometric assays combined with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
